Troendle August J.

About Troendle August J.

Dr. August J. Troendle is the founder, Chief Executive Officer, and Chairman of the Board of Medpace Holdings, Inc., a U.S.-listed clinical research organization. Company disclosures state that he founded Medpace in July 1992 and also served as President through July 31, 2021. His career is closely tied to healthcare, clinical development, and pharmaceutical research, supported by both medical and business training. He earned his medical degree from the University of Maryland School of Medicine and an MBA from Boston University. Under his leadership, Medpace grew into a contract research organization focused on supporting the development of drugs and medical devices. His responsibilities have included setting strategic direction, overseeing operational growth, and helping build the company’s international platform for biopharmaceutical clients. Troendle’s background combines scientific expertise with a strong understanding of regulatory, clinical, and commercial priorities. As a founder-CEO, he has been associated with the company’s long-term evolution, including its development from an early-stage business launched in the early 1990s into a publicly traded global services provider. Public company materials consistently identify him as both CEO and chairman, underscoring his sustained role in governance and strategic oversight. His tenure is often viewed as a source of continuity, operational discipline, and alignment around Medpace’s long-term mission. Professionally, Troendle is linked to clinical program leadership, medical and scientific decision-making, and the management of complex customer relationships in the life sciences sector. For corporate governance and market-profile purposes, he stands out as a founder who has maintained central influence over the direction of a U.S. public company in the healthcare services space.